Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines

Scientific relevance. The content of Bordetella pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertus...

Full description

Bibliographic Details
Main Authors: I. A. Alekseeva, I. V. Ibragimkhalilova, D. N. Lepekhova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2023-10-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/488
_version_ 1797244464942546944
author I. A. Alekseeva
I. V. Ibragimkhalilova
D. N. Lepekhova
author_facet I. A. Alekseeva
I. V. Ibragimkhalilova
D. N. Lepekhova
author_sort I. A. Alekseeva
collection DOAJ
description Scientific relevance. The content of Bordetella pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertussis vaccines, it is both relevant and necessary to study the relationship between the toxicity of B. pertussis bacterial cell components and the main quality parameters of these vaccines, including their potency and specific toxicity, as termed in the WHO recommendations and the European Pharmacopoeia.Aim. This study aimed to analyse the effects of B. pertussis LOS and residual active PT on the specific toxicity and potency of adsorbed diphtheria, tetanus, and whole-cell pertussis (DTwP) vaccines.Materials and methods. The authors tested 57 commercial batches of adsorbed DTwP vaccines for compliance with the regulatory standards and product specification files. Vaccine batches that failed specific toxicity tests formed Group 1, and the other batches were designated as Group 2. The potency was tested in F1 CBA/Ca×C57BL/6J hybrid mice with experimentally induced meningoencephalitis that were immunised with DTwP and reference vaccines. The authors assessed the specific toxicity of DTwP vaccines by changes in body weight following intraperitoneal administration. The toxic activity was assessed indirectly by changes in body weight in the first 16–24 h (B. pertussis LOS) and on day 7 (PT) after dosing. The authors used Spearman’s rank correlation coefficient to measure the strength of correlation between the toxic activity of vaccine components and the specific toxicity and potency of the vaccine, which were established using the same vaccine batches.Results. The authors measured the toxic activity of LOS and residual active PT in the vaccine batches studied. The correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of LOS were 0.113 (p&gt;0.05) and 0.049 (p&gt;0.05), respectively. Similarly, the correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of PT accounted for 0.595 (p&lt;0.01) and –0.534 (p&lt;0.01), respectively.Conclusions. The authors studied the toxic activity of B. pertussis LOS and residual active PT in whole-cell pertussis vaccines and found an inverse correlation between the potency of the vaccines and the toxic activity of residual active PT. The study demonstrated that the specific toxicity test for whole-cell pertussis vaccines fails to detect and quantify B. pertussis LOS in the samples. The authors advise to determine the content of LOS in the B. pertussis strains intended for the production of whole-cell pertussis vaccines, which is not yet an accepted practice in the Russian Federation.
first_indexed 2024-03-08T21:42:48Z
format Article
id doaj.art-1d5ebf3d10394a3da9b117e8c2d8819b
institution Directory Open Access Journal
issn 2221-996X
2619-1156
language Russian
last_indexed 2024-04-24T19:11:26Z
publishDate 2023-10-01
publisher Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Биопрепараты: Профилактика, диагностика, лечение
spelling doaj.art-1d5ebf3d10394a3da9b117e8c2d8819b2024-03-26T09:10:54ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562023-10-0123333334710.30895/2221-996X-2023-23-3-333-347334Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccinesI. A. Alekseeva0I. V. Ibragimkhalilova1D. N. Lepekhova2Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific relevance. The content of Bordetella pertussis lipo-oligosaccharide (LOS) and the residual levels of active pertussis toxin (PT) are generally accepted to be the primary factors that determine the reactogenicity of whole-cell pertussis vaccines. To improve the quality of whole-cell pertussis vaccines, it is both relevant and necessary to study the relationship between the toxicity of B. pertussis bacterial cell components and the main quality parameters of these vaccines, including their potency and specific toxicity, as termed in the WHO recommendations and the European Pharmacopoeia.Aim. This study aimed to analyse the effects of B. pertussis LOS and residual active PT on the specific toxicity and potency of adsorbed diphtheria, tetanus, and whole-cell pertussis (DTwP) vaccines.Materials and methods. The authors tested 57 commercial batches of adsorbed DTwP vaccines for compliance with the regulatory standards and product specification files. Vaccine batches that failed specific toxicity tests formed Group 1, and the other batches were designated as Group 2. The potency was tested in F1 CBA/Ca×C57BL/6J hybrid mice with experimentally induced meningoencephalitis that were immunised with DTwP and reference vaccines. The authors assessed the specific toxicity of DTwP vaccines by changes in body weight following intraperitoneal administration. The toxic activity was assessed indirectly by changes in body weight in the first 16–24 h (B. pertussis LOS) and on day 7 (PT) after dosing. The authors used Spearman’s rank correlation coefficient to measure the strength of correlation between the toxic activity of vaccine components and the specific toxicity and potency of the vaccine, which were established using the same vaccine batches.Results. The authors measured the toxic activity of LOS and residual active PT in the vaccine batches studied. The correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of LOS were 0.113 (p&gt;0.05) and 0.049 (p&gt;0.05), respectively. Similarly, the correlation coefficients between the specific toxicity and potency of the vaccines and the toxic activity of PT accounted for 0.595 (p&lt;0.01) and –0.534 (p&lt;0.01), respectively.Conclusions. The authors studied the toxic activity of B. pertussis LOS and residual active PT in whole-cell pertussis vaccines and found an inverse correlation between the potency of the vaccines and the toxic activity of residual active PT. The study demonstrated that the specific toxicity test for whole-cell pertussis vaccines fails to detect and quantify B. pertussis LOS in the samples. The authors advise to determine the content of LOS in the B. pertussis strains intended for the production of whole-cell pertussis vaccines, which is not yet an accepted practice in the Russian Federation.https://www.biopreparations.ru/jour/article/view/488whole-cell pertussis vaccinewp vaccinepotencyspecific toxicityvaccine reactogenicitypertussis component toxic activity<i>bordetella pertussis</i> lipo-oligosaccharidepertussis toxin
spellingShingle I. A. Alekseeva
I. V. Ibragimkhalilova
D. N. Lepekhova
Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
Биопрепараты: Профилактика, диагностика, лечение
whole-cell pertussis vaccine
wp vaccine
potency
specific toxicity
vaccine reactogenicity
pertussis component toxic activity
<i>bordetella pertussis</i> lipo-oligosaccharide
pertussis toxin
title Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
title_full Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
title_fullStr Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
title_full_unstemmed Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
title_short Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
title_sort effects of pertussis toxin and i bordetella pertussis i lipo oligosaccharide on the specific toxicity and potency of whole cell pertussis vaccines
topic whole-cell pertussis vaccine
wp vaccine
potency
specific toxicity
vaccine reactogenicity
pertussis component toxic activity
<i>bordetella pertussis</i> lipo-oligosaccharide
pertussis toxin
url https://www.biopreparations.ru/jour/article/view/488
work_keys_str_mv AT iaalekseeva effectsofpertussistoxinandibordetellapertussisilipooligosaccharideonthespecifictoxicityandpotencyofwholecellpertussisvaccines
AT ivibragimkhalilova effectsofpertussistoxinandibordetellapertussisilipooligosaccharideonthespecifictoxicityandpotencyofwholecellpertussisvaccines
AT dnlepekhova effectsofpertussistoxinandibordetellapertussisilipooligosaccharideonthespecifictoxicityandpotencyofwholecellpertussisvaccines